Japanese pharmaceutical retailer, Ain, has unveiled plans to acquire its competitor, Kraft, which operates the Sakura pharmacy chain. The proposed transaction is estimated to be worth over 100 billion yen (approximately US$690 million).
Ain’s intention is to purchase the entirety of Kraft’s shares from investment firm Nippon Sangyo Suishin Kiko. The deal, which includes assuming all the company’s debts, is estimated to cost Ain nearly 60 billion yen. If all goes to plan, the transaction is expected to be finalized in August.
In the business year ending April 2024, Ain’s dispensing pharmacy business reported strong sales figures of 357.5 billion yen. On the other hand, Kraft’s sales for the business year ending March 2024 were reported at 153.7 billion yen.
By acquiring Kraft, Ain aims to cement its leading position over its competitor Nihon Chouzai. The latter posted impressive sales of 321.9 billion yen in the last fiscal year.
What is the estimated value of the acquisition deal between Ain and Kraft?
The proposed acquisition deal is estimated to be worth over 100 billion yen (approximately US$690 million).
What is the expected completion date for the transaction?
The acquisition transaction is expected to be finalized in August.
What were the sales figures for Ain and Kraft in the last business year?
Ain’s dispensing pharmacy business reported sales figures of 357.5 billion yen in the business year ending April 2024, while Kraft posted sales of 153.7 billion yen for the same period.
